(ODD) ODDITY Tech Ordinary Shares - Ratings and Ratios

Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0011974909

Makeup, Skincare, Haircare, Supplements, Biotech

ODD EPS (Earnings per Share)

EPS (Earnings per Share) of ODD over the last years for every Quarter: "2022-03": 0.053253956462989, "2022-06": 0.28911304347826, "2022-09": 0.014317019334847, "2022-12": -0.011673069168241, "2023-03": 0.34647791667551, "2023-06": 0.53054099369654, "2023-09": 0.067809919986417, "2023-12": 0.023524048344638, "2024-03": 0.14356409888357, "2024-06": 0.73377314665462, "2024-09": 0.28694272157536, "2024-12": 0.087311920104155, "2025-03": 0.62715095653327, "2025-06": 0.79064730889548,

ODD Revenue

Revenue of ODD over the last years for every Quarter: 2022-03: 90.414, 2022-06: 97.659, 2022-09: 20.273438, 2022-12: 67.499, 2023-03: 165.654, 2023-06: 151.311, 2023-09: 94.474, 2023-12: 25.442883, 2024-03: 57.755906, 2024-06: 192.774, 2024-09: 118.998, 2024-12: 123.64, 2025-03: 268.076, 2025-06: 241.14,

Description: ODD ODDITY Tech Ordinary Shares

Oddity Tech Ltd. is a consumer tech company that leverages AI-driven technology to develop and market beauty and wellness products through its digital-first brands, including IL MAKIAGE and SpoiledChild. The companys online platform utilizes data science, machine learning, and computer vision to identify consumer needs and create tailored solutions.

From a business perspective, Oddity Techs strategy of combining technology and biotechnology to develop innovative products is noteworthy. The companys ODDITY LABS biotechnology center is a key differentiator, enabling the discovery of novel ingredients that drive performance and outcomes in the beauty and wellness industries. Key Performance Indicators (KPIs) to monitor include revenue growth, customer acquisition costs, and customer retention rates, which are crucial in assessing the companys ability to scale its digital-first brands.

The companys financials indicate a strong return on equity (RoE) of 31.59%, suggesting effective use of shareholder capital. The price-to-earnings (P/E) ratio of 41.99 may indicate a premium valuation, potentially reflecting the markets expectations for future growth. To further evaluate the companys prospects, additional KPIs such as gross margin, operating expenses as a percentage of revenue, and cash flow generation should be examined.

From a growth perspective, the companys ability to expand its product portfolio and penetrate new markets will be critical. The use of AI-driven technology and biotechnology could provide a competitive edge, enabling the company to stay ahead of trends and consumer preferences. Monitoring the companys research and development (R&D) expenses as a percentage of revenue and its pipeline of new products will be essential in assessing its long-term growth prospects.

ODD Stock Overview

Market Cap in USD 3,357m
Sub-Industry Personal Care Products
IPO / Inception 2023-07-19

ODD Stock Ratings

Growth Rating 61.8%
Fundamental 81.3%
Dividend Rating -
Return 12m vs S&P 500 42.1%
Analyst Rating 4.11 of 5

ODD Dividends

Currently no dividends paid

ODD Growth Ratios

Growth Correlation 3m -79%
Growth Correlation 12m 80.4%
Growth Correlation 5y 56.2%
CAGR 5y 11.88%
CAGR/Max DD 5y 0.22
Sharpe Ratio 12m 0.46
Alpha 39.08
Beta 1.714
Volatility 48.94%
Current Volume 334.6k
Average Volume 20d 671.6k
Stop Loss 57.8 (-4%)
Signal -0.74

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income (110.1m TTM) > 0 and > 6% of Revenue (6% = 45.1m TTM)
FCFTA 0.11 (>2.0%) and ΔFCFTA 2.22pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 89.37% (prev 41.10%; Δ 48.27pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.12 (>3.0%) and CFO 133.7m > Net Income 110.1m (YES >=105%, WARN >=100%)
Net Debt (-634.0m) to EBITDA (136.4m) ratio: -4.65 <= 3.0 (WARN <= 3.5)
Current Ratio 6.32 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (62.3m) change vs 12m ago 0.55% (target <= -2.0% for YES)
Gross Margin 72.93% (prev 71.74%; Δ 1.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 93.01% (prev 71.40%; Δ 21.61pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1656 (EBITDA TTM 136.4m / Interest Expense TTM 76.0k) >= 6 (WARN >= 3)

Altman Z'' 6.34

(A) 0.61 = (Total Current Assets 798.3m - Total Current Liabilities 126.4m) / Total Assets 1.10b
(B) 0.26 = Retained Earnings (Balance) 290.4m / Total Assets 1.10b
(C) 0.16 = EBIT TTM 125.8m / Avg Total Assets 808.4m
(D) 0.39 = Book Value of Equity 293.3m / Total Liabilities 746.7m
Total Rating: 6.34 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 81.26

1. Piotroski 7.0pt = 2.0
2. FCF Yield 3.86% = 1.93
3. FCF Margin 16.77% = 4.19
4. Debt/Equity 1.68 = 1.23
5. Debt/Ebitda 4.33 = -2.50
6. ROIC - WACC 10.47% = 12.50
7. RoE 33.29% = 2.50
8. Rev. Trend 59.86% = 2.99
9. Rev. CAGR 146.1% = 2.50
10. EPS Trend 56.41% = 1.41
11. EPS CAGR 330.0% = 2.50

What is the price of ODD shares?

As of August 31, 2025, the stock is trading at USD 60.21 with a total of 334,635 shares traded.
Over the past week, the price has changed by -0.50%, over one month by -13.60%, over three months by -16.75% and over the past year by +66.19%.

Is ODDITY Tech Ordinary Shares a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, ODDITY Tech Ordinary Shares (NASDAQ:ODD) is currently (August 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 81.26 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ODD is around 56.44 USD . This means that ODD is currently overvalued and has a potential downside of -6.26%.

Is ODD a buy, sell or hold?

ODDITY Tech Ordinary Shares has received a consensus analysts rating of 4.11. Therefore, it is recommended to buy ODD.
  • Strong Buy: 4
  • Buy: 2
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ODD price?

Issuer Target Up/Down from current
Wallstreet Target Price 73.3 21.8%
Analysts Target Price 65.3 8.5%
ValueRay Target Price 64.1 6.4%

Last update: 2025-08-18 02:03

ODD Fundamental Data Overview

Market Cap USD = 3.36b (3.36b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 678.7m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 33.4056
P/S = 4.4649
P/B = 9.5576
Beta = 3.292
Revenue TTM = 751.9m USD
EBIT TTM = 125.8m USD
EBITDA TTM = 136.4m USD
Long Term Debt = 582.6m USD (from longTermDebt, last quarter)
Short Term Debt = 7.26m USD (from shortTermDebt, last quarter)
Debt = 589.9m USD (Calculated: Short Term 7.26m + Long Term 582.6m)
Net Debt = -634.0m USD (from netDebt column, last quarter)
Enterprise Value = 3.27b USD (3.36b + Debt 589.9m - CCE 678.7m)
Interest Coverage Ratio = 1656 (Ebit TTM 125.8m / Interest Expense TTM 76.0k)
FCF Yield = 3.86% (FCF TTM 126.1m / Enterprise Value 3.27b)
FCF Margin = 16.77% (FCF TTM 126.1m / Revenue TTM 751.9m)
Net Margin = 14.65% (Net Income TTM 110.1m / Revenue TTM 751.9m)
Gross Margin = 72.93% ((Revenue TTM 751.9m - Cost of Revenue TTM 203.5m) / Revenue TTM)
Tobins Q-Ratio = 11.14 (Enterprise Value 3.27b / Book Value Of Equity 293.3m)
Interest Expense / Debt = 0.01% (Interest Expense 76.0k / Debt 589.9m)
Taxrate = 20.65% (from yearly Income Tax Expense: 26.4m / 127.9m)
NOPAT = 99.8m (EBIT 125.8m * (1 - 20.65%))
Current Ratio = 6.32 (Total Current Assets 798.3m / Total Current Liabilities 126.4m)
Debt / Equity = 1.68 (Debt 589.9m / last Quarter total Stockholder Equity 351.2m)
Debt / EBITDA = 4.33 (Net Debt -634.0m / EBITDA 136.4m)
Debt / FCF = 4.68 (Debt 589.9m / FCF TTM 126.1m)
Total Stockholder Equity = 330.8m (last 4 quarters mean)
RoA = 10.03% (Net Income 110.1m, Total Assets 1.10b )
RoE = 33.29% (Net Income TTM 110.1m / Total Stockholder Equity 330.8m)
RoCE = 13.78% (Ebit 125.8m / (Equity 330.8m + L.T.Debt 582.6m))
RoIC = 20.95% (NOPAT 99.8m / Invested Capital 476.5m)
WACC = 10.49% (E(3.36b)/V(3.95b) * Re(12.33%)) + (D(589.9m)/V(3.95b) * Rd(0.01%) * (1-Tc(0.21)))
Shares Correlation 5-Years: 100.0 | Cagr: 4.14%
Discount Rate = 12.33% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 63.47% ; FCFE base≈94.9m ; Y1≈91.6m ; Y5≈90.5m
Fair Price DCF = 19.88 (DCF Value 880.2m / Shares Outstanding 44.3m; 5y FCF grow -4.73% → 3.0% )
Revenue Correlation: 59.86 | Revenue CAGR: 146.1%
Rev Growth-of-Growth: 49.17
EPS Correlation: 56.41 | EPS CAGR: 330.0%
EPS Growth-of-Growth: -26.05

Additional Sources for ODD Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle